A. Sandri et al., 8 DRUGS IN ONE-DAY CHEMOTHERAPY IN A NONFAMILIAL BILATERAL RETINOBLASTOMA WITH RECURRENT CEREBROSPINAL-FLUID METASTASES, Pediatric hematology and oncology, 15(6), 1998, pp. 557-561
A case of bilateral retinoblastoma with recurrent cerebrospinal fluid
(CSF) metastases is presented. The patient underwent left eye enucleat
ion and received external beam radiotherapy to the right eye. A sequen
tial combination chemotherapy, including cyclophosphamide, vincristine
, carboplatin, and etoposide with intrathecal drug administration, was
then adopted. During treatment a relapse within the central nervous s
ystem (CNS) occurred. The ''8-in-1-day'' chemotherapy, wed in our depa
rtment in medulloblastoma patients with CSF involvement was then consi
dered. The patient received 8 total courses, each with intrathecal dru
g administration No toxicity was experienced. The patient is alive and
free from CSF metastases after a period of 48 months and has been in
continuous complete remission (CCR) for 41 months. The authors conclud
e that the use of the ''8-in-1'' regimen is feasible and can be used i
n retinoblastoma patients with recurrent CSF metastases.